Q&A: Ned Sharpless on COVID-19 and Cancer Prevention | Citedby Results | Cancer Prevention Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Q&A: Ned Sharpless on COVID-19 and Cancer Prevention

Cancer Prev Res (Phila) (2021) 14 (6): 615–618.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting

Elizabeth Gaudio
Nariman Ammar
Fatma Gunturkun
Cem Akkus
Whitney Brakefield
Daniel V. Wakefield
Maria Pisu
Robert Davis
Arash Shaban-Nejad
David L. Schwartz

International Journal of Radiation Oncology*Biology*Physics (2023) 116 (2): 379.

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs

Goli Samimi
Margaret House
Kelly Benante
Lisa Bengtson
Troy Budd
Bridget Dermody
Katina DeShong
Valerie Dyer
Bruce F. Kimler
Vikrant V. Sahasrabuddhe
Suzanne Siminski
Leslie G. Ford
Eduardo Vilar
Eva Szabo

Cancer Prevention Research (2022) 15 (5): 279.